University of Crete (UOC)
Μελέτη της προγνωστικής σημασίας της ανίχνευσης μικρομεταστατικής νόσου στο αίμα και τον μυελό των οστών σε ασθενείς με καρκίνο του παχέος εντέρου σταδίου B2 και C κατά Astler Coller
Abstract
dc:descriptionPurpose: To evaluate the clinical relevance of circulating CEACAM5mRNA-positive cells in patients with operable colorectal cancer (CRC). Methods: Peripheral blood was obtained from 265 patients with operable CRC before the initiation of adjuvant systemic therapy, from 96 normal donors and the Lovo cell line as negative and positive controls, respectively. The detection of CEACAM5mRNA-positive cells was performed using a real time-PCR assay. The association with known prognostic factors and the effect of CEACAM5mRNA-positive cells on patients' prognosis was investigated. Results: The analytical detection limit of the method was found to correspond to 0.7 Lovo cell equivalence/5 μg RNA, with a sensitivity of 1 tumor cell/105 normal cells and a specificity of 97%. Ninety-eight (37%) patients had detectable circulating CEACAM5mRNA-positive cells. Detection of CEACAM5mRNA-positive cells was significantly associated with higher relapse rate (p<0.001), decreased Disease-Free Survival (DFS; p <0.001), higher death rate (p=0.017) and decreased median overall survival (p=0.025). Multivariate analysis revealed that the detection of circulating CEACAM5 mRNA-positive cells was an independent prognostic factor for decreased DFS (HR=3.4; 95% CI: 2.0-5.9; p<0.001). Conclusions: Detection of peripheral blood CEACAM5mRNA-positive cells is an adverse prognostic factor correlated with poor clinical outcome in patients with operable CRC.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vardakis, Nikolaos
- Βαρδάκης, Νικόλαος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25079